Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al - 25/01/22
Doi : 10.1016/j.rmed.2020.106061
Erin P. Silverman ⁎ 
, Raju Reddy, Ali Ataya, Christina Eagan
, Raju Reddy, Ali Ataya, Christina Eagan University of Florida, College of Medicine, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Gainesville, FL, USA
∗Corresponding author. Clinical Research Coordinator – UF College of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Adjunct Assistant Professor – UF College of Public Health and Health Professions, 1600 SW Archer Rd., Medical Sciences Building Room 442, PO Box 100225. Gainesville, FL 32610, USA.Clinical Research Coordinator – UF College of MedicineDivision of PulmonaryCritical Care and Sleep MedicineAdjunct Assistant Professor – UF College of Public Health and Health Professions1600 SW Archer Rd.Medical Sciences Building Room 442PO Box 100225GainesvilleFL32610USA
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : SARS-CoV-2, COVID-19, Infectivity, Letter to editor
Le texte complet de cet article est disponible en PDF.
Plan
© 2020
Elsevier Ltd. Tous droits réservés.
Vol 191
Article 106061- janvier 2022 Retour au numéro
Article précédent
- Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options
- Md Mohiuddin, Kazuo Kasahara
- Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”
- Eric D. Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather Burnett, Jerome Msihid, David Weinreich, Ian D. Pavord
Bienvenue sur EM-consulte, la référence des professionnels de santé.